Navigation Links
Hospira Highlights Progress in 2010 at Its 2011 Annual Meeting of Shareholders
Date:5/10/2011

LAKE FOREST, Ill., May 10, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today held its 2011 Annual Meeting of Shareholders in Washington, D.C. The agenda included votes on seven items as well as an update on the company's progress in 2010 and its position going forward.

"2010 was a year marked with milestone achievements, but also scattered challenges," said F. Michael Ball, chief executive officer. "Through a keen focus on staying the course, we transformed obstacles into opportunities. In 2011, we continue to deliver on our strategy, remaining focused on propelling Hospira towards a future of sustainable top-ranking performance and increased value for our shareholders."

During the annual meeting, shareholders:

  • elected the following directors: Irving W. Bailey, II; F. Michael Ball; and Jacque J. Sokolov, M.D.; all Class I directors whose terms expire in 2014;
  • approved three amendments to Hospira's restated certificate of incorporation;
  • approved, by means of a shareholder advisory vote, the compensation of Hospira's named executive officers ("say on pay") as disclosed in the 2011 proxy statement;
  • determined, by means of a shareholder advisory vote, that the "say-on-pay" vote will occur every year; and
  • ratified the appointment of Deloitte & Touche LLP as Hospira's auditors for 2011.

A full description of the above matters is included in Hospira's proxy statement related to the meeting. The proxy statement is available on Hospira's website at www.hospirainvestor.com, as are Mr. Ball's remarks.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hospira Reports First-Quarter 2011 Results
2. Hospira Board Authorizes $1 Billion Share Repurchase Program
3. Hospira to Present at Bank of America / Merrill Lynch 2011 Health Care Conference May 11, 2011
4. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
5. Hospira to Host Conference Call for First-Quarter 2011 Results
6. Hospira Submits 510(k) Application to FDA for Symbiq™ Infusion System Modifications
7. Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care
8. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
9. Hospira Announces U.S. Approval of Generic Docetaxel
10. Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role
11. Hospira MedNet™ Portal Safety Software Benchmarking System Debuts at HIMSS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... 2017 Research and Markets has announced ... Opportunities, and Future" report to their offering. ... This research service on the ... technologies, and provides a snapshot of the key participants in the ... are provided from 2016 to 2020. The market is expected to ...
(Date:1/20/2017)... -- Avillion LLP, a co-developer and financier of late-stage ... MD MBA as Chief Medical Officer. Dr Weinberg will be based ... ... spent more than 17 years as a pharmaceutical and biotech executive ... Over the course of his career, he has interfaced with the ...
(Date:1/19/2017)... , Jan. 19, 2017 The Global Therapy ... and access to partnering deals and agreements entered into ... in partnering deals - Top deals by value - ... development, technology type The report provides understanding and ... by the world,s leading healthcare companies. The report ...
Breaking Medicine Technology:
(Date:1/21/2017)... ... January 21, 2017 , ... In the United States, 20 million women ... of recovery, they often feel shame for having struggled with an eating disorder as ... the workshop, “Rising Strong in Life After an Eating Disorder” -- to be featured ...
(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between Goodwill® and Roadie, Inc. ... or need, from clothes to couches to dressers and bicycles. Roadie — the national ... the nearest Goodwill donation center through February 28th. , “January is an exciting ...
(Date:1/20/2017)... ... ... Doctor C LLC, a company based out of Arizona that focuses on ... marketing and distribution of its product, The Right C. , The Right C is ... traditional vitamin C supplements. At the trade show, Doctor C had the opportunity to ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... ... wellness products to enhance people’s everyday lives, recently attended the January ECRM Trade ... , ATP Science is known for its large range of supplements that keep ...
(Date:1/20/2017)... ... January 20, 2017 , ... "TransFlare 4K Mystique comes with 44 colorful mysterious ... X," said Christina Austin - CEO of Pixel Film Studios. , TransFlare 4K ... 4K Mystique lens flare and light leak transitions have a very high-dynamic range for ...
Breaking Medicine News(10 mins):